IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.444
NA - Nord America 6.175
AS - Asia 5.536
SA - Sud America 998
AF - Africa 78
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.247
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.753
US - Stati Uniti d'America 5.995
SG - Singapore 1.981
IE - Irlanda 1.730
CN - Cina 1.263
HK - Hong Kong 970
BR - Brasile 850
IT - Italia 807
UA - Ucraina 763
GB - Regno Unito 649
DE - Germania 600
FR - Francia 386
KR - Corea 386
VN - Vietnam 315
FI - Finlandia 228
SE - Svezia 210
IN - India 157
TR - Turchia 138
GR - Grecia 136
CA - Canada 131
JP - Giappone 126
AR - Argentina 49
AT - Austria 42
PL - Polonia 37
ID - Indonesia 36
BD - Bangladesh 34
MX - Messico 30
EC - Ecuador 26
BE - Belgio 25
IQ - Iraq 21
PK - Pakistan 20
ZA - Sudafrica 20
CL - Cile 16
ES - Italia 16
NL - Olanda 16
PE - Perù 14
SC - Seychelles 13
CZ - Repubblica Ceca 11
MA - Marocco 11
VE - Venezuela 11
CO - Colombia 10
IL - Israele 9
PY - Paraguay 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
KZ - Kazakistan 7
TN - Tunisia 7
AZ - Azerbaigian 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EG - Egitto 6
IR - Iran 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
UZ - Uzbekistan 6
EU - Europa 5
KE - Kenya 5
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
PT - Portogallo 4
TH - Thailandia 4
AU - Australia 3
CG - Congo 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
RS - Serbia 3
BH - Bahrain 2
CY - Cipro 2
DZ - Algeria 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
Totale 28.239
Salva come PNG Salva come JPEG
Città #
Moscow 3.493
Dublin 1.722
Jacksonville 1.174
Hong Kong 968
Santa Clara 950
Chandler 805
Singapore 756
Seoul 371
Princeton 244
Medford 216
New York 169
Hefei 168
Caserta 143
Ann Arbor 142
Roxbury 141
Beijing 140
Boardman 140
Ashburn 136
Bremen 133
San Mateo 125
Bengaluru 122
Naples 122
Munich 100
Elora 97
Wilmington 97
Ho Chi Minh City 89
Dallas 75
Woodbridge 74
São Paulo 68
The Dalles 66
Nanjing 65
Hanoi 59
Los Angeles 53
Dong Ket 52
Cambridge 51
Des Moines 50
Nuremberg 48
Napoli 46
Jinan 37
Mountain View 29
Rio de Janeiro 28
Kraków 26
Milan 26
Brussels 24
Tianjin 24
Belo Horizonte 23
Helsinki 23
Houston 22
Curitiba 19
Norwalk 19
Vienna 19
Aversa 18
Turku 18
Zhengzhou 18
Hangzhou 17
Rome 16
Shenyang 16
Brasília 15
Changsha 15
Düsseldorf 15
Guangzhou 15
Jakarta 15
Tokyo 15
Aiello Del Sabato 14
Nanchang 13
Shanghai 13
Auburn Hills 12
Ottawa 12
Guarulhos 11
Lanzhou 11
Porto Alegre 11
Taizhou 11
Brno 10
Ercolano 10
Lima 10
London 10
Salvador 10
San Francisco 10
Biên Hòa 9
Brooklyn 9
Da Nang 9
Falkenstein 9
Guayaquil 9
Haiphong 9
Istanbul 9
Jiaxing 9
Toronto 9
Trieste 9
Campinas 8
Chennai 8
Chicago 8
Hải Dương 8
Lappeenranta 8
Ningbo 8
Quito 8
Redwood City 8
Santiago 8
Amsterdam 7
Atlanta 7
Baghdad 7
Totale 14.333
Salva come PNG Salva come JPEG
Nome #
ONCOLOGIA MEDICA 197
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 196
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 191
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 179
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 168
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 165
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 165
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 164
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 164
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 163
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 161
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 158
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 157
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 157
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 157
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 157
Clinical management of advanced gastric cancer: Role of new molecular drugs. 156
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 156
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 156
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 154
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 154
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 150
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 150
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 150
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 150
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 149
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 149
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 148
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 148
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 147
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 146
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 146
Predictive biomarkers along gastric cancer pathogenetic pathways 144
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 144
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 143
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 142
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 142
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 142
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 141
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 140
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 139
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 138
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 138
Treatment of gastric cancer. 136
Adult Wilms' tumor: a case report 136
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 135
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 135
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 134
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 134
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 133
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 133
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 132
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 132
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 131
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 130
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 130
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 129
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 129
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 128
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 128
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 128
Farmacogenomica e cancro colorettale 127
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 126
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 125
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 125
Cardiotossicità da antracicline: attualità e prospettive 125
TRASTUZUMAB RESISTANCE IN BREAST CANCER 125
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 124
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 123
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 123
Adjuvant chemotherapy of gastric cancer: which regimen? 122
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 121
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 121
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 121
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 120
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 120
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 119
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 118
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 118
Chemoradiotherapy as adjuvant treatment of gastric cancer 117
Targeting EGFR in Pancreatic Cancer Treatment. 117
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 116
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 116
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 116
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 116
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 116
Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery 115
Integrated therapy in localized gastric cancer: targeted and tailored approach. 115
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 115
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 115
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 115
Ventricular repolarization time indexes following anthracycline treatment 115
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 115
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 115
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 114
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 114
Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis 113
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 113
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 113
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 113
Totale 13.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 0 0 0 13 234 186 39 217 171 99
2021/20221.453 134 10 16 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/202613.667 593 826 815 843 1.354 9.236 0 0 0 0 0 0
Totale 28.823